UNIGE document Scientific Article
previous document  unige:78753  next document
add to browser collection
Title

Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments

Authors
Saigi Morgui, Nuria
Delacrétaz, Aurélie
Gholam-Rezaee, Mehdi
show hidden authors show all authors [1 - 17]
Published in Pharmacogenetics and Genomics. 2015, vol. 25, no. 5, p. 246-258
Abstract Metabolic syndrome (MetS) associated with psychiatric disorders and psychotropic treatments represents a major health issue. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an enzyme that catalyzes tissue regeneration of active cortisol from cortisone. Elevated enzymatic activity of 11β-HSD1 may lead to the development of MetS.
Identifiers
PMID: 25751397
Full text
Article (Published version) (162 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Médecine psychosomatique, neurosciences cliniques et mindfulness (690)
Citation
(ISO format)
QUTEINEH, Lina et al. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. In: Pharmacogenetics and Genomics, 2015, vol. 25, n° 5, p. 246-258. doi: 10.1097/FPC.0000000000000131 https://archive-ouverte.unige.ch/unige:78753

334 hits

0 download

Update

Deposited on : 2015-12-17

Export document
Format :
Citation style :